3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
12
INDUSTRY
2
NETWORK
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Urinary Bladder Neoplasms
18
Pancreatic Neoplasms
17
Lung Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Biliary Tract Neoplasms
10
Urethral Neoplasms
9
Lymphoma
8
Uterine Cervical Neoplasms
6
Ovarian Neoplasms
6
Gallbladder Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Large-Cell, Anaplastic
4
Hodgkin Disease
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms
4
Sarcoma
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Salivary Gland Neoplasms
2
Recurrent Uterine Corpus Sarcoma
2
Recurrence
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Immunoblastic Lymphadenopathy
2
Fallopian Tube Neoplasms
2
Adenocarcinoma of Lung
2
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
Gemcitabine
×
Clear all
NCT02718482
2019-05-13
OsteoREC2015
Italian Sarcoma Group
Phase 2
Terminated
7 enrolled